Generics, copies and original drugs: Are they really interchangeable? Investigations on nimesulide-containing preparations

Journal of Clinical Research

Volumn 4, Issue 77-89, 2001, Pages 77-89

  Hutt, V ^a   Waitzinger, J ^a  

^a AAI Deutschland GmbH and Co KG   (Germany)

Author keywords

Copy product; Generic product; In vitro in vivo correlation; Metabolite 4' hydroxy nimesulide; Nimesulide; Original product; Pharmacokinetics; Relative bioavailability

Indexed keywords

GENERIC DRUG; NIMESULIDE; NIMESULIDE DOROM; SULIDAMOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG MARKETING; DRUG SOLUBILITY; GOOD CLINICAL PRACTICE; GOOD LABORATORY PRACTICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ITALY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; STATISTICAL ANALYSIS;

EID: 0035674094     PISSN: 13695207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Non 41 steroidal anti-inflammatories - XII. Mode of action of anti-inflammatory methane sulfonanilides
2. Nimesulide: An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
3. Nimesulide: A selective cyclo-oxygenase 2 inhibitor anti-inflammatory drug
4. In vitro and in vivo pharmacological evidence of selective cyclo-oxygenase-2 inhibition by nimesulide: An overview
5. The in vivo assessment of nimesulide cyclooxygenase-2 selectivity
6. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors
7. Nimesulide: An NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities
8. Comparative efficacy and safety of the non-steroidal anti-inflammatory drugs nimesulide and diclofenac in patients with acute subdeltoid bursitis and bicipital tendinitis
9. Clinical pharmacokinetics of nimesulide
10. Comparative in vitro evaluation of nimesulide-containing preparations on the Italian market
11. Review of methods and criteria for the evaluation of bioequivalence studies
12. The use of non-parametric methods in the statistical analysis of the two-period change-over design
13. max for absorption rates in investigations of bioequivalence
14. Bioinequivalence and drug toxicity
15. Comparative bioavailability study of two different nimesulide-containing preparations available on the Italian market